EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study

Yuya Seko iD, Kanji Yamaguchi iD, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Ola Fjellström, Jenny E Blau und 3 weitere

Liver International · 2023

DOI: 10.1111/liv.15678 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, 2023. Verfasst von Yuya Seko und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims PNPLA3 rs738409 has been associated with an increased risk of liver‐related events in patients with non‐alcoholic fatty liver disease (NAFLD). In this study, we investigated the epidemiology of NAFLD and the impact of PNPLA3 on prognosis in Japan.

Methods

A longitudinal multicentre cohort study, the JAGUAR study, includes 1550 patients with biopsy‐proven NAFLD in Japan. We performed genetic testing and evaluated outcomes from this cohort. Liver‐related events were defined as hepatocellular carcinoma (HCC) and decompensated liver cirrhosis events.

Results

During follow‐up (median [range], 7.1 [1.0–24.0] years), 80 patients developed HCC, 104 developed liver‐related events, and 59 died of any cause. The 5‐year rate of liver‐related events for each single‐nucleotide polymorphism was 0.5% for CC, 3.8% for CG, and 5.8% for GG. Liver‐related deaths were the most common ( n = 28); only three deaths were due to cardiovascular disease. Multivariate analysis identified carriage of PNPLA3 CG/GG (hazard ratio [HR] 16.04, p = .006) and FIB‐4 index >2.67 (HR 10.70, p < .01) as predictors of liver‐related event development. No HCC or liver‐related death was found among patients with PNPLA3 CC. There was a significantly increased risk of HCC, liver‐related events, and mortality for CG/GG versus CC, but no difference between the CG and GG genotypes.

Conclusions

In Japanese individuals, the main cause of death from NAFLD is liver‐related death. The greater risk of liver‐related events incurred by PNPLA3 G allele was shown in Japan. Risk stratification for NAFLD in Japan is best accomplished by integrating PNPLA3 with the FIB‐4 index.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansCarcinoma, HepatocellularCohort StudiesEast Asian PeopleGenetic Predisposition to DiseaseGenotypeLiver NeoplasmsPolymorphism, Single NucleotidePrognosisJapanFollow-Up StudiesRisk AssessmentLiver CirrhosisAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

CVDHCCNAFLDPNPLA3mortality

Substanzen

PNPLA3 protein, humanAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Japan.
  • Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Liver Center, Saga University Hospital, Saga, Japan.
  • General Internal Medicine 2, General Medical Center, Kawasaki Medical School, Okayama, Japan.
  • Center for Digestive and Liver Diseases, Nara City Hospital, Nara, Japan.

ORCID-Profile: Yuya Seko, Kanji Yamaguchi, Takeshi Okanoue

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Seko, Y., Yamaguchi, K., Shima, T., Iwaki, M., Takahashi, H., Kawanaka, M., Tanaka, S., Mitsumoto, Y., Yoneda, M., Nakajima, A., Fjellström, O., Blau, J. E., Carlsson, B., Okanoue, T., & Itoh, Y. (2023). The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study. Liver International. https://doi.org/10.1111/liv.15678

Vancouver

Seko Y, Yamaguchi K, Shima T, Iwaki M, Takahashi H, Kawanaka M, et al. The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study. Liver International. 2023. doi:10.1111/liv.15678

BibTeX
@article{Seko2023,
  author = {Seko, Yuya and Yamaguchi, Kanji and Shima, Toshihide and Iwaki, Michihiro and Takahashi, Hirokazu and Kawanaka, Miwa and Tanaka, Saiyu and Mitsumoto, Yasuhide and Yoneda, Masato and Nakajima, Atsushi and Fjellström, Ola and Blau, Jenny E and Carlsson, Björn and Okanoue, Takeshi and Itoh, Yoshito},
  title = {The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15678}
}
Kostenlos starten →